The P2X7 receptor: A novel biomarker of uterine epithelial cancers

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 10, 2006, Pages 1906-1913

  Li, Xin ^a   Zhou, Lingying ^a   Feng, Ying Hong ^c   Abdul Karim, Fadi W ^b   Gorodeski, George I ^a,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PURINE P2X7 RECEPTOR; RECEPTOR ANTIBODY; TUBULIN; PURINE P2 RECEPTOR; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; KERATINOCYTE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX DYSPLASIA; UTERINE ENDOCERVIX; UTERUS; UTERUS CANCER; WESTERN BLOTTING; ADENOMA; CASE CONTROL STUDY; CHEMISTRY; FEASIBILITY STUDY; METABOLISM; MIDDLE AGED; MIXED MULLERIAN TUMOR; NEOPLASM; PATHOLOGY; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; MIXED TUMOR, MULLERIAN; NEOPLASMS, GLANDULAR AND EPITHELIAL; POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS;

EID: 33750516489     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0407     Document Type: Article

References (22)

1. Buell G, Collo G, Rassendren F. P2X receptors: an emerging channel family. Eur J Neurosci 1996;8:2221-8.
2. Soto F, Garcia-Guzman M, Stuhmer W. Cloned ligand-gated channels activated by extracellular ATP (P2X receptors). J Membr Biol 1997;160:91-100.
3. Dubyak GR, el-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993;265:C577-606.
4. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998;50:413-92.
5. Khakh BS, Burnstock G, Kennedy C, et al. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 2001;53:107-18.
6. Virginio C, MacKenzie A, North RA, Surprenant A. Kinetics of cell lysis, dye uptake, and permeability changes in cells expressing the rat P2X7 receptor. J Physiol 1999;519:335-46.
7. Wang Q, Wang L, Feng YH, Li X, Zeng R, Gorodeski GI. P2X7-receptor mediated apoptosis of human cervical epithelial cells. Am J Physiol 2004;287:C1349-58.
8. Wang Q, Li X, Wang L, Feng YH, Zeng R, Gorodeski GI. Anti-apoptoric effects of estrogen in normal and in cancer human cervical epithelial cells. Endocrinology 2004;145:5568-79.
9. Feng YH, Li X, Wang L, Zhou L, Gorodeski GI. A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J Biol Chem 2006;281:17228-37.
10. Wang L, Feng YH, Gorodeski GI. EGF facilitates epinephrine inhibition of P2X7-receptor mediated pore formation and apoptosis: a novel signaling network. Endocrinology 2005;146:164-74.
11. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002;82:1013-67.
12. Gorodeski GI, Romero MF, Hopfer U, Rorke E, Utian WH, Eckert RL. Human uterine cervical epithelial cells grown on permeable support-a new model for the study of differentiation and transepithelial transport. Differentiation 1994;56:107-18.
13. Gorodeski GI, Merlin D, De Santis BJ, et al. Characterization of paracellular permeability in cultured human cervical epithelium: regulation by extracellular ATP. J Soc Gynecol Investig 1994;1:225-33.
14. Feng YH, Wang L, Wang Q, Li X, Zeng R, Gorodeski GI. ATP ligation stimulates GRK-3-mediated phosphorylation and β-arrestin-2- and dynamin-dependent internalization of the P2X7-receptor. Am J Physiol 2005;288:C1342-56.
15. Zeng R, Li X, Gorodeski GI. Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation. J Clin Endocrinol Metab 2004;89:5145-55.
16. Zhu L, Li X, Zeng R, Gorodeski GI. Changes in tight junctional resistance of the cervical epithelium are associated with modulation of content and phosphorylation of occludin 65-kilodalton and 50-kilodalton forms. Endocrinology 2006;147:977-89.
17. Gorodeski GI, Eckert RL, Utian WH, Sheean L, Rorke EA. Retinoids, sex steroids, and glucocorticoids regulate ectocervical cell envelope formation but not the level of the envelope precursor, involucrin. Differentiation 1989;42:75-80.
18. Bardini M, Lee HY, Burnstock G. Distribution of P2X receptor subtypes in the rat female reproductive tract at late pro-oestrus/early oestrus. Cell Tissue Res 2000;299:105-13.
19. Available from: http://www.nlm.nih.gov/medlineplus/uterinecancer.html.
20. Buell GN, Talabot F, Gos A, et al. Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels 1998;6:347-54.
21. Barreau C, Paillard L, Osborne HB. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 2005;33:7138-50.
22. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005;353:2158-68.